Does CEFOXITIN Cause Product use in unapproved indication? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Product use in unapproved indication have been filed in association with CEFOXITIN (Cefoxitin and Dextrose). This represents 3.5% of all adverse event reports for CEFOXITIN.
26
Reports of Product use in unapproved indication with CEFOXITIN
3.5%
of all CEFOXITIN reports
2
Deaths
5
Hospitalizations
How Dangerous Is Product use in unapproved indication From CEFOXITIN?
Of the 26 reports, 2 (7.7%) resulted in death, 5 (19.2%) required hospitalization, and 2 (7.7%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CEFOXITIN. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does CEFOXITIN Cause?
Drug reaction with eosinophilia and systemic symptoms (78)
Drug resistance (63)
Rash (47)
Off label use (46)
Nausea (44)
Drug ineffective (39)
Condition aggravated (38)
Thrombocytopenia (35)
Rash maculo-papular (34)
Treatment failure (33)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which CEFOXITIN Alternatives Have Lower Product use in unapproved indication Risk?
CEFOXITIN vs CEFPODOXIME
CEFOXITIN vs CEFPODOXIME PROXETIL
CEFOXITIN vs CEFPROZIL
CEFOXITIN vs CEFTAROLINE
CEFOXITIN vs CEFTAROLINE FOSAMIL